Imagin Molecular Corporation (IMGM.OB) Provides PET Imaging Services
Through its three wholly-owned subsidiaries, Imagin Molecular Corporation owns and operates several positron emission tomography (PET) imaging centers across North America. The company's main focal points are the business opportunities provided by the detection of disease in the brain and heart, and the diagnosis of some forms of cancer. In simplified terms, PET imaging is the practice of injecting radioactive isotopes, or tracers, into a living subject for the purpose of constructing a three-dimensional map of potentially diseased tissues/organs. Upon introduction to the patient's circulatory system, the radioisotopes begin to decay, emitting positrons, which are the antimatter counterparts of electrons.…